» Articles » PMID: 35408474

Anti-Depressant Properties of Crocin Molecules in Saffron

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2022 Apr 12
PMID 35408474
Authors
Affiliations
Soon will be listed here.
Abstract

Saffron is a valued herb, obtained from the stigmas of the Linn (Iridaceae), with therapeutic effects. It has been described in pharmacopoeias to be variously acting, including as an anti-depressant, anti-carcinogen, and stimulant agent. The therapeutic effects of saffron are harbored in its bioactive molecules, notably crocins, the subject of this paper. Crocins have been demonstrated to act as a monoamine oxidase type A and B inhibitor. Furthermore, saffron petal extracts have experimentally been shown to impact contractile response in electrical field stimulation. Other research suggests that saffron also inhibits the reuptake of monoamines, exhibits -methyl-d-aspartate antagonism, and improves brain-derived neurotrophic factor signaling. A host of experimental studies found saffron/crocin to be similarly effective as fluoxetine and imipramine in the treatment of depression disorders. Saffron and crocins propose a natural solution to combat depressive disorders. However, some hurdles, such as stability and delivery, need to be overcome.

Citing Articles

Phytochemicals in the treatment of patients with depression: a systemic review.

Picheta N, Piekarz J, Danilowska K, Mazur K, Piecewicz-Szczesna H, Smolen A Front Psychiatry. 2024; 15:1509109.

PMID: 39717381 PMC: 11663887. DOI: 10.3389/fpsyt.2024.1509109.


Comparative Evaluation of Antidepressant and Anxiolytic Effects of Escitalopram, Crocin, and their Combination in Rats.

Joodaki M, Radahmadi M, Alaei H Adv Biomed Res. 2024; 13:99.

PMID: 39717248 PMC: 11665166. DOI: 10.4103/abr.abr_259_23.


Comparing the Efficacy of Escitalopram with and without Crocin in Restoring I/O Functions and LTP within the Hippocampal CA1 Region of Stressed Rats.

Joodaki M, Radahmadi M, Alaei H Adv Biomed Res. 2024; 13:116.

PMID: 39717236 PMC: 11665179. DOI: 10.4103/abr.abr_18_24.


Plants with Potential Importance in Supporting the Treatment of Depression: Current Trends, and Research.

Nurzynska-Wierdak R Pharmaceuticals (Basel). 2024; 17(11).

PMID: 39598400 PMC: 11597216. DOI: 10.3390/ph17111489.


Molecular and Behavioral Neuroprotective Effects of Clavulanic Acid and Crocin in Haloperidol-Induced Tardive Dyskinesia in Rats.

Shoae-Hagh P, Razavi B, Sadeghnia H, Mehri S, Karimi G, Hosseinzadeh H Mol Neurobiol. 2024; 62(4):5156-5182.

PMID: 39520654 DOI: 10.1007/s12035-024-04566-x.


References
1.
Sarris J, Kavanagh D, Byrne G, Bone K, Adams J, Deed G . The Kava Anxiety Depression Spectrum Study (KADSS): a randomized, placebo-controlled crossover trial using an aqueous extract of Piper methysticum. Psychopharmacology (Berl). 2009; 205(3):399-407. DOI: 10.1007/s00213-009-1549-9. View

2.
Jelodar G, Javid Z, Sahraian A, Jelodar S . Saffron improved depression and reduced homocysteine level in patients with major depression: A Randomized, double-blind study. Avicenna J Phytomed. 2018; 8(1):43-50. PMC: 5787996. View

3.
Ghajar A, Neishabouri S, Velayati N, Jahangard L, Matinnia N, Haghighi M . Crocus sativus L. versus Citalopram in the Treatment of Major Depressive Disorder with Anxious Distress: A Double-Blind, Controlled Clinical Trial. Pharmacopsychiatry. 2016; 50(4):152-160. DOI: 10.1055/s-0042-116159. View

4.
Hausenblas H, Saha D, Dubyak P, Anton S . Saffron (Crocus sativus L.) and major depressive disorder: a meta-analysis of randomized clinical trials. J Integr Med. 2013; 11(6):377-83. PMC: 4643654. DOI: 10.3736/jintegrmed2013056. View

5.
Hosseinzadeh H, Talebzadeh F . Anticonvulsant evaluation of safranal and crocin from Crocus sativus in mice. Fitoterapia. 2005; 76(7-8):722-4. DOI: 10.1016/j.fitote.2005.07.008. View